These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22325420)

  • 1. A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.
    Hsu H; Khare SD; Lee F; Miner K; Hu YL; Stolina M; Hawkins N; Chen Q; Ho SY; Min H; Xiong F; Boone T; Zack DJ
    Clin Exp Rheumatol; 2012; 30(2):197-201. PubMed ID: 22325420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel BAFF antagonist, BAFF-Trap, effectively alleviates the disease progression of systemic lupus erythematosus in MRL/lpr mice.
    Yu C; Chen S; Zhou B; Zhang H; Su X; Luo Y; Yang L
    Mol Immunol; 2021 Jan; 129():1-11. PubMed ID: 33254074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An increase in B cell apoptosis by interfering BAFF-BAFF-R interaction with small synthetic molecules.
    Moon EY; Yi KY; Lee S
    Int Immunopharmacol; 2011 Oct; 11(10):1523-33. PubMed ID: 21620999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
    Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
    Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KR33426, [2-(2,5-dichlorophenyl)-5-methyloxazol-4yl]carbonylguanidine, is a novel compound to be effective on mouse systemic lupus erythematosus.
    Lee GH; Oh JM; Kim HS; Yoon WK; Yi KY; Yang Y; Han SH; Lee S; Moon EY
    Eur J Pharmacol; 2011 Oct; 668(3):459-66. PubMed ID: 21827747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oridonin ameliorates lupus-like symptoms of MRL(lpr/lpr) mice by inhibition of B-cell activating factor (BAFF).
    Zhou L; Sun L; Wu H; Zhang L; Chen M; Liu J; Zhong R
    Eur J Pharmacol; 2013 Sep; 715(1-3):230-7. PubMed ID: 23712004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents.
    Shu JL; Zhang XZ; Han L; Zhang F; Wu YJ; Tang XY; Wang C; Tai Y; Wang QT; Chen JY; Chang Y; Wu HX; Zhang LL; Wei W
    Acta Pharmacol Sin; 2019 Jun; 40(6):801-813. PubMed ID: 30446734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis.
    Zhang M; Ko KH; Lam QL; Lo CK; Srivastava G; Zheng B; Lau YL; Lu L
    Int Immunol; 2005 Aug; 17(8):1081-92. PubMed ID: 16000326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases.
    Sun J; Lin Z; Feng J; Li Y; Shen B
    Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment.
    Zhang M; Lee F; Knize A; Jacobsen F; Yu S; Ishida K; Miner K; Gaida K; Whoriskey J; Chen C; Gunasekaran K; Hsu H
    Clin Exp Rheumatol; 2019; 37(6):906-914. PubMed ID: 30789152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and differences between selective and nonselective BAFF blockade in murine SLE.
    Ramanujam M; Wang X; Huang W; Liu Z; Schiffer L; Tao H; Frank D; Rice J; Diamond B; Yu KO; Porcelli S; Davidson A
    J Clin Invest; 2006 Mar; 116(3):724-34. PubMed ID: 16485042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice.
    Ding H; Wang L; Wu X; Yan J; He Y; Ni B; Gao W; Zhong X
    J Cell Mol Med; 2010 Jun; 14(6B):1717-25. PubMed ID: 19627403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers.
    Figgett WA; Deliyanti D; Fairfax KA; Quah PS; Wilkinson-Berka JL; Mackay F
    J Autoimmun; 2015 Jul; 61():9-16. PubMed ID: 26027434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis.
    Vallerskog T; Heimbürger M; Gunnarsson I; Zhou W; Wahren-Herlenius M; Trollmo C; Malmström V
    Arthritis Res Ther; 2006; 8(6):R167. PubMed ID: 17092341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAFF and its receptors involved in the inflammation progress in adjuvant induced arthritis rats.
    Wei F; Xu S; Jia X; Sun X; Yang X; Wei W; Chang Y
    Int Immunopharmacol; 2016 Feb; 31():1-8. PubMed ID: 26688104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic effects of PADRE-BAFF autovaccine on rat adjuvant arthritis.
    Feng GD; Xue XC; Gao ML; Wang XF; Shu Z; Mu N; Gao Y; Wang ZL; Hao Q; Li WN; Li M; Zhang C; Zhang W; Zhang YQ
    Biomed Res Int; 2014; 2014():854954. PubMed ID: 24791002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel BLyS Peptibody Down-Regulates B Cell and T Helper Cell Subsets In Vivo and Ameliorates Collagen-Induced Arthritis.
    Zhu W; Sun X; Zhu L; Gan Y; Baiwu R; Wei J; Li Z; Li R; Sun J
    Inflammation; 2016 Apr; 39(2):839-48. PubMed ID: 26861221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?
    Binard A; Le Pottier L; Saraux A; Devauchelle-Pensec V; Pers JO; Youinou P
    J Autoimmun; 2008; 30(1-2):63-7. PubMed ID: 18155417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
    Samy E; Wax S; Huard B; Hess H; Schneider P
    Int Rev Immunol; 2017 Jan; 36(1):3-19. PubMed ID: 28215100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.